Google +
 
   
 

Multimedia

Highlights include the latest organization video and Public Service Announcements.

 

 

LEARN MORE

 

Press Kit

View The Miami Project's mission, background, scientific overview and our experts with their background.

REVIEW

 

In the News

Dr. Allan LeviNovel Stem Cell Trial for Cervical Spinal Cord Injury to Start with the Miller School's Miami Project

READ MORE

Publications

2014 Fall Project MagazineThe Project, published bi-annually, is the official magazine of The Miami Project and The Buoniconti Fund and are available electronically.  Our Annual Research Review summarizes a selection of research publications from the past year.  Register for our monthly e-news, The Connection.

READ MORE

Research Achievements

Dr. Diana Cardenas

 

The broad scope of research carried out at The Miami Project has focused on answering questions that help define human spinal cord injury and reveal strategies for the repair of damaged spinal tissue...MORE

 

 

CUTTING EDGE SCIENCE

 

NOVEL STEM TRIAL FOR CERVICAL SPINAL CORD INJURY TO

START WITH THE MILLER SCHOOL'S MIAMI PROJECT

 

Allan D. O. Levi, M.D.October 2014 – A novel clinical trial using human neural stem cells for the treatment of cervical spinal cord injury is beginning at the Miller School of Medicine. Allan D. Levi, M.D., Ph.D, professor and Robert M. Buck Distinguished Chair in Neurological Surgery, is the principal investigator of the Pathway® Study, which is the first clinical study designed to evaluate both the safety and efficacy of transplanting stem cells into patients with traumatic injury to the cervical spinal cord.

The trial will use HuCNS-SC® cells, purified human neural stem cells developed by StemCells, Inc., a leader in the research and development of cell-based therapies for the treatment of disorders of the central nervous system. The trial will be conducted as a randomized, controlled, single-blind study and efficacy will be primarily measured by assessing motor function according to the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The primary efficacy outcome will focus on change in upper extremity strength as measured in the hands, arms, and shoulders. The trial will follow the patients for one year from the time of enrollment.

Levi is a clinical researcher at The Miami Project to Cure Paralysis, a Center of Excellence at the Miller School, which is also conducting the first ever clinical trial of Schwann cell transplantation in patients with a new spinal cord injury among five other FDA approved clinical trials.

 

 

Read more

 

 

 

UPCOMING EVENTS

 

Wednesday - December 3, 2014

Gail F. Beach Memorial Visiting Lectureship Series
12pm

LPLC 7th Floor Apex Auditorium

  

“Inflammation and TBI Pathophysiology”

 

Pramod K. Dash,PhD
Professor
Departments of Neurobiology and Anatomy, Neurosurgery
Director of Research
The Vivian L. Smith Center for Neurologic Research
University of Texas Medical School   Houston, TX


 

Friday - December 5, 2014

Neuroscience Center Seminar Series
12pm

LPLC 7th Floor Apex Auditorium

 

"The Assembly and Evolution
of Neural Circuits for Locomotion"


Jeremy S. Dasen, PhD

Associate Professor
NYU Neuroscience Institute
Department of Neuroscience and Physiology
NYU School of Medicine

 

 

Upcoming Lectures

 

 

2014 Fall Project Magazine

 

 

 
 
 
The Miami Project to Cure Paralysis
1095 NW 14th Terrace
Lois Pope LIFE Center
Miami, FL  33136 USA
p. (305) 243-6001 or 1.800.STAND UP
f. (305) 243-6017
e. miamiproject@med.miami.edu
 
Copyright 2014 University of Miami, All Rights Reserved.